Financial Data and Key Metrics Changes - For the third quarter of fiscal 2025, total revenue decreased to approximately $26,200,000, representing a decline of 12.7% or $3,800,000 compared to $30,000,000 in the same period last year [17] - Gross profit for Q3 was approximately $4,800,000, down from approximately $6,100,000 for the same period last year, with gross margins decreasing to 18.2% from 20.4% [19] - The net loss for Q3 was $10,900,000 or $0.19 per share, compared to a net loss of $5,900,000 or $0.11 per share for the same period last year [21] - As of March 31, 2025, cash and cash equivalents were $23,500,000, a reduction of $10,900,000 compared to the previous quarter [21] Business Line Data and Key Metrics Changes - Revenue from North America decreased by $3,600,000 or 28.9% to approximately $8,800,000, largely due to new tariffs on Chinese products and the transition of manufacturing to Malaysia [18] - European revenues slightly declined by $300,000 or 2.9% to approximately $13,200,000 [18] - Asia Pacific revenues decreased by $800,000 or 21.4% to approximately $3,000,000, primarily due to reduced demand in South Korea [18] Market Data and Key Metrics Changes - The company is experiencing a shift in market dynamics due to pending increases in tariffs on Chinese-made goods, impacting product pricing [9] - The black market for vaping products in the U.S. is estimated to be between $5.5 billion to $70 billion, significantly larger than the legal market [29] Company Strategy and Development Direction - The company aims to become a leading manufacturer of precision dosing technology for global nicotine companies, focusing on managing accounts receivable and enhancing financial stability [6][7] - The interim nicotine product manufacturing license secured in Malaysia is a key part of the global business strategy, allowing for expanded manufacturing capacity and reduced geopolitical risks [10] - The company is shifting its pricing strategy from landed pricing to FOB factory pricing to enhance flexibility and strengthen market position [9] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about converting consumers from black market products to compliant products with the new age gating technology [29] - The company anticipates that the benefits of its North American restructuring will begin to be realized in fiscal Q4 2025 [21] - Management is focused on driving a more profitable business model through Malaysian operations and high-quality customer engagement [16] Other Important Information - The company has filed a PMPA for its blockchain-based age gating system with the FDA, which is a necessary step towards regulation in the industry [11] - The Malaysian facility will feature 80 production lines, significantly expanding manufacturing capacity [10] Q&A Session Summary Question: What could the FDA's focus on port shopping mean for illicit vape supply in the U.S.? - Management believes the new technology will convert many consumers from gray or black market products to compliant products, with the black market estimated to be significantly larger than the legal market [29][30] Question: Are there specific countries in the EU market that the company is excited about? - Management indicated that the UK and EU's move to ban disposables will benefit the company, as it has a strong brand presence in pod systems [34] Question: How are customer reactions to new hardware devices in the U.S.? - Management highlighted the launch of the SPROUT and VOLT platforms, which are designed to set new safety and performance standards in the industry [41][44] Question: What alternatives do customers have regarding tariffs? - Management noted that most U.S. cannabis customers have agreed to switch to FOB factory pricing, which helps mitigate tariff risks [48]

Financial Data and Key Metrics Changes - For the third quarter of fiscal 2025, total revenue decreased to approximately $26,200,000, representing a decline of 12.7% or $3,800,000 compared to $30,000,000 in the same period last year [17][21] - Gross profit for Q3 was approximately $4,800,000, down from approximately $6,100,000 for the same period last year, with gross margins decreasing to 18.2% from 20.4% [19][21] - The net loss for Q3 was $10,900,000 or $0.19 per share, compared to a net loss of $5,900,000 or $0.11 per share for the same period last year [21] Business Line Data and Key Metrics Changes - Revenue from North America decreased by approximately $3,600,000 or 28.9% to $8,800,000, largely due to new tariffs on Chinese products and the transition of manufacturing to Malaysia [18] - European revenues slightly declined by $300,000 or 2.9% to approximately $13,200,000 [18] - Asia Pacific revenues decreased by $800,000 or 21.4% to approximately $3,000,000, primarily due to reduced demand in South Korea [18] Market Data and Key Metrics Changes - The company reported a focus on higher quality customers, which has impacted revenue collection and overall performance [19] - The pending increase in tariffs on Chinese-made goods has affected product pricing dynamics, but the company expects to be less impacted due to manufacturing in Malaysia [10] Company Strategy and Development Direction - The company aims to become a leading manufacturer of precision dosing technology for global nicotine companies, with significant progress made in the third quarter [7] - The interim nicotine product manufacturing license secured in Malaysia is a central part of the global business strategy [10] - The company is shifting its pricing strategy from landed pricing to FOB factory pricing to enhance flexibility and strengthen market position [10] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about converting consumers from the black market to compliant products with the new age gating technology [28] - The company anticipates that the Malaysian facility will significantly expand manufacturing capacity and reduce geopolitical risks [11] - Management highlighted ongoing discussions with global nicotine providers and the potential for significant market opportunities [24] Other Important Information - The company has filed a PMPA for its blockchain-based age gating system with the FDA, which is seen as a necessary step towards regulation in the industry [12] - The launch of the Sprout device, developed in partnership with Raw Garden, emphasizes the company's commitment to safety and performance in the cannabis market [15] Q&A Session Summary Question: What does the FDA's focus on port shopping mean for illicit vape supply in the U.S.? - Management believes the new technology will convert consumers from the black market to compliant products, with estimates suggesting the black market could be worth between $5.5 billion to $70 billion [28] Question: Are there specific countries in the EU market that the company is excited about? - Management indicated that the UK and EU's move to ban disposables will benefit the company, as it has a strong brand presence in pod systems [32] Question: How are customer reactions to new hardware devices in the U.S.? - Management noted positive reactions to the new Sprout and Vault platforms, which aim to set new safety and performance standards in the industry [41][44] Question: What alternatives do customers have regarding tariffs? - Management discussed successful renegotiations with U.S. cannabis customers to switch to FOB factory pricing, which helps mitigate tariff impacts [48]

Financial Data and Key Metrics Changes - For the third quarter of fiscal 2025, total revenue decreased to approximately $26,200,000, representing a decline of 12.7% or $3,800,000 compared to $30,000,000 in the same period last year [17][21] - Gross profit for Q3 was approximately $4,800,000, down from approximately $6,100,000 for the same period last year, with gross margins decreasing to 18.2% from 20.4% [19][21] - The net loss for Q3 was $10,900,000 or $0.19 per share, compared to a net loss of $5,900,000 or $0.11 per share for the same period last year [21] Business Line Data and Key Metrics Changes - Revenue from North America decreased by $3,600,000 or 28.9% to approximately $8,800,000, largely due to new tariffs on Chinese products and the transition of manufacturing to Malaysia [18] - European revenues slightly declined by $300,000 or 2.9% to approximately $13,200,000 [18] - Asia Pacific revenues decreased by $800,000 or 21.4% to approximately $3,000,000, primarily due to reduced demand in South Korea [18] Market Data and Key Metrics Changes - The company reported a focus on higher quality customers, which has impacted revenue but is expected to improve accounts receivable collection [19] - The pending increase in tariffs on Chinese-made goods has affected product pricing dynamics, but the company anticipates less impact due to manufacturing in Malaysia [8][18] Company Strategy and Development Direction - The company aims to become a leading manufacturer of precision dosing technology for global nicotine companies, with significant progress made in securing manufacturing licenses and optimizing pricing strategies [6][10] - The interim nicotine product manufacturing license in Malaysia is a key part of the global business strategy, allowing the company to market its capabilities externally [9][10] - The company is transitioning to FOB factory pricing to enhance flexibility and strengthen market position [8][23] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about converting consumers from the black market to compliant products with the approval of new technology [28] - The company is focused on innovation, regulatory compliance, and financial stability to capitalize on market opportunities [24] - Management acknowledged the challenges posed by tariffs but highlighted successful renegotiations with customers to mitigate risks [47] Other Important Information - The company has launched new products, including the Sprout device for cannabis and the Vault platform for vaping, aimed at setting new industry standards [13][40] - The Malaysian facility is expected to feature 80 production lines, significantly expanding manufacturing capacity [10][34] Q&A Session Summary Question: Impact of FDA regulations on illicit vape supply in the U.S. - Management believes the new technology will convert consumers from the black market to compliant products, with estimates suggesting the black market could be worth between $5.5 billion to $70 billion [28] Question: EU disposable vape bans and supply constraints - Management is optimistic about benefiting from the EU's shift away from disposable products and does not foresee supply chain constraints due to the new manufacturing capabilities in Malaysia [32][33] Question: Customer reactions to new hardware devices and tariff alternatives - Management reported positive reactions to the new Sprout and Vault products, emphasizing their focus on safety and performance [40][43] - The company has successfully renegotiated contracts to FOB factory pricing to help customers manage tariff impacts [47]